Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

Open access

Abstract

Key Points: Genetic analysis reveals frequent 9p24.1/PD-L1/PD-L2 copy-number alterations and increased expression of the PD-1 ligands in PCNSL and PTL. PD-1 blockade with nivolumab demonstrated activity in patients with relapsed/refractory PCNSL and PTL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2017-01-764209

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 464

Metadata

Authors
Nayak, L., Iwamoto, F. M., LaCasce, A., Mukundan, S., Roemer, M. G. M., Chapuy, B., Armand, P., Rodig, S. J., & Shipp, M. A.
Affiliations
  • Brigham and Women's Hospital (US)
  • NewYork–Presbyterian Hospital (US)
  • Dana-Farber Cancer Institute (US)
Venue
Blood
Published
2017-06-08
Volume
129
Issue
23
Pages
3071-3073
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2600581432
Cited by
453
References
23
Citations by year
2026: 15 · 2025: 35 · 2024: 48 · 2023: 49 · 2022: 50 · 2021: 58 · 2020: 59 · 2019: 50 · 2018: 57 · 2017: 30
FWCI
37.34
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA161026)
Topics
  • Health Sciences › Medicine › Clinical Neurology › CNS Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
nivolumab, anti-PD-1 therapy, primary central nervous system lymphoma, testicular lymphoma, relapsed/refractory lymphoma, PD-L1, PD-L2, PD-1 ligands, immune checkpoint inhibitors
MeSH terms
Nivolumab, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antineoplastic Agents, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Testicular Neoplasms, Tomography, X-Ray Computed, Lymphoma, B-Cell, Central Nervous System Neoplasms, Treatment Outcome, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma. https://app.cochat.ai/papers/10.1182/blood-2017-01-764209
The paper
Nayak, L., Iwamoto, F. M., LaCasce, A., Mukundan, S., Roemer, M. G. M., Chapuy, B., Armand, P., Rodig, S. J., & Shipp, M. A. (2017). PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma. Blood. https://doi.org/10.1182/blood-2017-01-764209

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.